Biotech company lays off 15% of staff

Absci, a company using generative artificial intelligence in the drug discovery process, laid off 30 employees or about 15 percent of its staff, GeekWire reported Sept. 6.

Advertisement

The layoffs were related to the “company’s continued realization of operational efficiencies from its AI and wet lab integration.” About a year ago, the company laid off 40 employees. 

The company’s stock is down more than 20 percent this year. Absci went public in 2021.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Digital Health

  • Hospitals are increasingly paying for artificial intelligence by the token, turning a once-obscure technical term into a line item finance…

  • Hospital leaders often measure cybersecurity readiness by asking whether their own environment is protected. Are systems patched? Is multifactor authentication…

Advertisement

Comments are closed.